Closure of patent forman ovale defects using GORE® CARDIOFORM septal occluder

Stefan E. Hardt, Andreas Eicken, Felix Berger, Stephan Schubert, Mario Carminati, Gianfranco Butera, Jochen Grohmann, Rene Höhn, Jens Erik Nielsen-Kudsk, David Hildick-Smith, Magnus Settergren, John D. Thomson, Nicolas Geis, Lars Søndergaard

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims: The GORE® CARDIOFORM Septal Occluder (GSO) is a novel device designed for rapid and effective closure of patent foramen ovale (PFO) which has distinctive features making it suitable for a broad spectrum of anatomical variations. We report the procedural and 6 months follow-up results of the first prospective, multicenter study using GSO. Methods and Results: This single-arm study included 150 subjects undergoing closure of PFO in 10 European centers. In 149 out of 150 patients implantation of a GSO device was successful. One patient had a different PFO-closure device implanted. Periprocedural complications were few including one patient with suspected transient ischemic attack, two access site bleedings, and one patient with AV-fistula. No device embolization occurred. During the 6-month follow-up period one patient had a transient asymptomatic thrombus on the device and four patients (2.6%) were diagnosed new onset paroxysmal atrial fibrillation, which were successfully treated. No thrombembolic events occurred. Closure was successful in 94.2% of subjects at discharge evaluation and 96.9% at 6 months follow-up. Conclusion: This prospective, multicenter study adds to previous published data and suggests that GSO is a versatile device for PFO closure with high procedural and closure success rates and low complication rates through mid-term follow-up.

Original languageEnglish
JournalCatheterization and Cardiovascular Interventions
DOIs
Publication statusAccepted/In press - Jan 1 2017

Fingerprint

Septal Occluder Device
Patent Foramen Ovale
Equipment and Supplies
Multicenter Studies
Prospective Studies
Transient Ischemic Attack
Atrial Fibrillation
Fistula
Thrombosis
Hemorrhage

Keywords

  • ASD/PDA/PFO
  • Closure
  • Stroke
  • Structural heart disease intervention

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Closure of patent forman ovale defects using GORE® CARDIOFORM septal occluder. / Hardt, Stefan E.; Eicken, Andreas; Berger, Felix; Schubert, Stephan; Carminati, Mario; Butera, Gianfranco; Grohmann, Jochen; Höhn, Rene; Nielsen-Kudsk, Jens Erik; Hildick-Smith, David; Settergren, Magnus; Thomson, John D.; Geis, Nicolas; Søndergaard, Lars.

In: Catheterization and Cardiovascular Interventions, 01.01.2017.

Research output: Contribution to journalArticle

Hardt, SE, Eicken, A, Berger, F, Schubert, S, Carminati, M, Butera, G, Grohmann, J, Höhn, R, Nielsen-Kudsk, JE, Hildick-Smith, D, Settergren, M, Thomson, JD, Geis, N & Søndergaard, L 2017, 'Closure of patent forman ovale defects using GORE® CARDIOFORM septal occluder', Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.26993
Hardt, Stefan E. ; Eicken, Andreas ; Berger, Felix ; Schubert, Stephan ; Carminati, Mario ; Butera, Gianfranco ; Grohmann, Jochen ; Höhn, Rene ; Nielsen-Kudsk, Jens Erik ; Hildick-Smith, David ; Settergren, Magnus ; Thomson, John D. ; Geis, Nicolas ; Søndergaard, Lars. / Closure of patent forman ovale defects using GORE® CARDIOFORM septal occluder. In: Catheterization and Cardiovascular Interventions. 2017.
@article{11c320ccc77e4f9193d291100d41f26d,
title = "Closure of patent forman ovale defects using GORE{\circledR} CARDIOFORM septal occluder",
abstract = "Aims: The GORE{\circledR} CARDIOFORM Septal Occluder (GSO) is a novel device designed for rapid and effective closure of patent foramen ovale (PFO) which has distinctive features making it suitable for a broad spectrum of anatomical variations. We report the procedural and 6 months follow-up results of the first prospective, multicenter study using GSO. Methods and Results: This single-arm study included 150 subjects undergoing closure of PFO in 10 European centers. In 149 out of 150 patients implantation of a GSO device was successful. One patient had a different PFO-closure device implanted. Periprocedural complications were few including one patient with suspected transient ischemic attack, two access site bleedings, and one patient with AV-fistula. No device embolization occurred. During the 6-month follow-up period one patient had a transient asymptomatic thrombus on the device and four patients (2.6{\%}) were diagnosed new onset paroxysmal atrial fibrillation, which were successfully treated. No thrombembolic events occurred. Closure was successful in 94.2{\%} of subjects at discharge evaluation and 96.9{\%} at 6 months follow-up. Conclusion: This prospective, multicenter study adds to previous published data and suggests that GSO is a versatile device for PFO closure with high procedural and closure success rates and low complication rates through mid-term follow-up.",
keywords = "ASD/PDA/PFO, Closure, Stroke, Structural heart disease intervention",
author = "Hardt, {Stefan E.} and Andreas Eicken and Felix Berger and Stephan Schubert and Mario Carminati and Gianfranco Butera and Jochen Grohmann and Rene H{\"o}hn and Nielsen-Kudsk, {Jens Erik} and David Hildick-Smith and Magnus Settergren and Thomson, {John D.} and Nicolas Geis and Lars S{\o}ndergaard",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/ccd.26993",
language = "English",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Closure of patent forman ovale defects using GORE® CARDIOFORM septal occluder

AU - Hardt, Stefan E.

AU - Eicken, Andreas

AU - Berger, Felix

AU - Schubert, Stephan

AU - Carminati, Mario

AU - Butera, Gianfranco

AU - Grohmann, Jochen

AU - Höhn, Rene

AU - Nielsen-Kudsk, Jens Erik

AU - Hildick-Smith, David

AU - Settergren, Magnus

AU - Thomson, John D.

AU - Geis, Nicolas

AU - Søndergaard, Lars

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Aims: The GORE® CARDIOFORM Septal Occluder (GSO) is a novel device designed for rapid and effective closure of patent foramen ovale (PFO) which has distinctive features making it suitable for a broad spectrum of anatomical variations. We report the procedural and 6 months follow-up results of the first prospective, multicenter study using GSO. Methods and Results: This single-arm study included 150 subjects undergoing closure of PFO in 10 European centers. In 149 out of 150 patients implantation of a GSO device was successful. One patient had a different PFO-closure device implanted. Periprocedural complications were few including one patient with suspected transient ischemic attack, two access site bleedings, and one patient with AV-fistula. No device embolization occurred. During the 6-month follow-up period one patient had a transient asymptomatic thrombus on the device and four patients (2.6%) were diagnosed new onset paroxysmal atrial fibrillation, which were successfully treated. No thrombembolic events occurred. Closure was successful in 94.2% of subjects at discharge evaluation and 96.9% at 6 months follow-up. Conclusion: This prospective, multicenter study adds to previous published data and suggests that GSO is a versatile device for PFO closure with high procedural and closure success rates and low complication rates through mid-term follow-up.

AB - Aims: The GORE® CARDIOFORM Septal Occluder (GSO) is a novel device designed for rapid and effective closure of patent foramen ovale (PFO) which has distinctive features making it suitable for a broad spectrum of anatomical variations. We report the procedural and 6 months follow-up results of the first prospective, multicenter study using GSO. Methods and Results: This single-arm study included 150 subjects undergoing closure of PFO in 10 European centers. In 149 out of 150 patients implantation of a GSO device was successful. One patient had a different PFO-closure device implanted. Periprocedural complications were few including one patient with suspected transient ischemic attack, two access site bleedings, and one patient with AV-fistula. No device embolization occurred. During the 6-month follow-up period one patient had a transient asymptomatic thrombus on the device and four patients (2.6%) were diagnosed new onset paroxysmal atrial fibrillation, which were successfully treated. No thrombembolic events occurred. Closure was successful in 94.2% of subjects at discharge evaluation and 96.9% at 6 months follow-up. Conclusion: This prospective, multicenter study adds to previous published data and suggests that GSO is a versatile device for PFO closure with high procedural and closure success rates and low complication rates through mid-term follow-up.

KW - ASD/PDA/PFO

KW - Closure

KW - Stroke

KW - Structural heart disease intervention

UR - http://www.scopus.com/inward/record.url?scp=85015151581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015151581&partnerID=8YFLogxK

U2 - 10.1002/ccd.26993

DO - 10.1002/ccd.26993

M3 - Article

AN - SCOPUS:85015151581

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

ER -